On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
HOME > LATEST
LATEST
-
BUSINESS Iclusig Gets Additional FDA Nod for Iclusig in Ph+ ALL: Takeda
March 25, 2024
-
BUSINESS Novartis, Sandoz Recall Entacapone Products over Carcinogenic Risk
March 25, 2024
-
BUSINESS Kobayashi Pharma Recalls Supplements on Reports of Kidney Disorders
March 25, 2024
-
REGULATORY Chuikyo Agrees to Exempt PD-1/PD-L1, JAK Classes from Spillover Re-Pricing
March 25, 2024
-
REGULATORY Xocova’s Price to Remain Intact after Full Approval, No Change in Clinical Positioning
March 25, 2024
-
REGULATORY Japan Set to Push Central IRBs for Clinical Trials, Avoid Customary All-Case PMS
March 22, 2024
-
REGULATORY Pharma Regulation Panel Wraps Up Debate, Report to Be Finalized Soon
March 22, 2024
-
BUSINESS Japan, US CROs to Collaborate to Address Drug Lags/Losses
March 22, 2024
-
BUSINESS Astellas Gives 1.5% Pay Raise to Acquire Best Talents
March 22, 2024
-
REGULATORY 1 Year on, China Mulling Potential Indictment of Detained Astellas Employee
March 22, 2024
-
ORGANIZATION FPMAJ Lays Out Planned Activities for FY2024
March 22, 2024
-
ORGANIZATION Scrap Off-Year Drug Revision as It Mars Innovation, Supply: JPMA Official
March 22, 2024
-
BUSINESS FDA Clears Orchard’s Lenmeldy Gene Therapy for MLD
March 22, 2024
-
REGULATORY Japan Awards Orphan Tag to Janssen’s Talquetamab, 2 More APIs
March 22, 2024
-
COLUMN How to Paint an Irresistible Picture of Success
March 22, 2024
-
REGULATORY Japan Resumes Debate on Rx-to-OTC Switch of PPIs after Over 5 Years
March 22, 2024
-
BUSINESS Will Kyowa Kirin’s Eye Drops for nAMD Replace Intraocular Injections? PII Now Underway
March 21, 2024
-
BUSINESS Meiji’s Bivalent COVID Jab Hits Primary Goal in PIII Omicron Trial; New Strains Eyed
March 21, 2024
-
REGULATORY New LDP Project Team Launched to Boost Global Access to Infectious Disease Drugs
March 21, 2024
-
BUSINESS Arexvy Already January GP Rep Promotion Champion, Tarlige Tops HP Ranking
March 21, 2024
ページ
Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…